Sharpening the boundaries of Parkinson-associated dementia: recommendation for a neuropsychological diagnostic procedure
- PMID: 20119649
- DOI: 10.1007/s00702-010-0370-2
Sharpening the boundaries of Parkinson-associated dementia: recommendation for a neuropsychological diagnostic procedure
Abstract
Older adults suffering from Parkinson's disease (PD) frequently present with an additional form of severe neurodegenerative and/or vascular pathology. Findings of differential clinical manifestations of cognitive impairment, depending on presence and nature of such coexisting brain pathology, raise the question for neuropsychological procedures that are capable not only of distinguishing between non-demented PD patients and patients with Parkinson-associated dementia (PDD), but also of detecting other types of cognitive decline, most likely Alzheimer's disease (AD) or vascular dementia (VD), superimposing PD. The aim of this article is to review the literature on neuropsychological processes at risk in developing PDD, to introduce comorbid causes of cognitive decline in the presence of PD, to discuss the scope of the "cortical versus subcortical dementia"-concept in view of its capability of differentiating dementias, and to scrutinize existing diagnostic criteria concerning the toleration of comorbidity. Additionally, we derive an evidence-based neuropsychological diagnostic procedure for assessing PDD under special consideration of these comorbid aspects.
Similar articles
-
Cognitive profiles and optimal cut-offs for routine cognitive tests in elderly individuals with Parkinson's disease, Parkinson's disease dementia, Alzheimer's disease, and normal cognition.Psychogeriatrics. 2020 Jan;20(1):20-27. doi: 10.1111/psyg.12451. Epub 2019 Mar 25. Psychogeriatrics. 2020. PMID: 30912230
-
Parkinson's disease dementia: Diagnostic criteria and risk factor review.J Clin Exp Neuropsychol. 2015;37(9):988-93. doi: 10.1080/13803395.2015.1073227. J Clin Exp Neuropsychol. 2015. PMID: 26332178 Review.
-
Cognitive complaints in Parkinson's disease patients: from subjective cognitive complaints to dementia and affective disorders.J Neural Transm (Vienna). 2019 Oct;126(10):1329-1335. doi: 10.1007/s00702-019-02042-8. Epub 2019 Jul 5. J Neural Transm (Vienna). 2019. PMID: 31278557
-
Cognitive dysfunction and dementia in Parkinson disease.Mov Disord. 2007 Sep;22 Suppl 17:S358-66. doi: 10.1002/mds.21677. Mov Disord. 2007. PMID: 18175397 Review.
-
Neuropsychological characteristics of dementia with Lewy bodies and Parkinson's disease with dementia: differentiation, early detection, and implications for "mild cognitive impairment" and biomarkers.Neuropsychol Rev. 2008 Mar;18(1):103-19. doi: 10.1007/s11065-008-9055-0. Epub 2008 Mar 6. Neuropsychol Rev. 2008. PMID: 18322801 Review.
Cited by
-
Differential sialylation of serpin A1 in the early diagnosis of Parkinson's disease dementia.PLoS One. 2012;7(11):e48783. doi: 10.1371/journal.pone.0048783. Epub 2012 Nov 8. PLoS One. 2012. PMID: 23144969 Free PMC article.
-
Towards Consensus on Essential Components of Physical Examination in Primary Care-based Memory Clinics.Can Geriatr J. 2018 Jun 30;21(2):143-151. doi: 10.5770/cgj.21.296. eCollection 2018 Jun. Can Geriatr J. 2018. PMID: 29977429 Free PMC article.
-
Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines.Mov Disord. 2012 Mar;27(3):349-56. doi: 10.1002/mds.24893. Epub 2012 Jan 24. Mov Disord. 2012. PMID: 22275317 Free PMC article. Review.
-
Profile of cognitive impairment in late-stage Parkinson's disease.Brain Behav. 2022 Apr;12(4):e2537. doi: 10.1002/brb3.2537. Epub 2022 Mar 7. Brain Behav. 2022. PMID: 35254007 Free PMC article.
-
Parkinson's disease dementia and potential therapeutic strategies.CNS Neurosci Ther. 2011 Feb;17(1):32-44. doi: 10.1111/j.1755-5949.2010.00216.x. Epub 2010 Dec 28. CNS Neurosci Ther. 2011. PMID: 21199444 Free PMC article. Review.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical